메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 26, Issue 12, 2008, Pages 2040-2041
Eosinophilia with FIP1L1-PDGFRA fusion in a patient with chronic myelomonocytic leukemia
Author keywords

[No Author keywords available]
Indexed keywords

ARSENIC TRIOXIDE; ASCORBIC ACID; DEXAMETHASONE; HYBRID PROTEIN; PROTEIN FIP1L1; PROTEIN PDGFRA; THALIDOMIDE; UNCLASSIFIED DRUG; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; FIP1L1 PDGFRA FUSION PROTEIN, HUMAN; FIP1L1-PDGFRA FUSION PROTEIN, HUMAN; ONCOPROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR;
EID: 42949099364     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.15.3841     Document Type: Article
Times cited : (8)
References (10)
  • 1
    • 0344987881 scopus 로고    scopus 로고
    • A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome
    • Cools J, DeAngelo DJ, Gotlib J, et al: A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348:1201-1214, 2003
    • (2003) N Engl J Med , vol.348 , pp. 1201-1214
    • Cools, J.1    DeAngelo, D.J.2    Gotlib, J.3
  • 2
    • 8644263305 scopus 로고    scopus 로고
    • FIP1L1-PDGFRA fusion: Prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia
    • Pardanani A, Brockman SR, Paternoster SF, et al: FIP1L1-PDGFRA fusion: Prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. Blood 104:3038-3045, 2004
    • (2004) Blood , vol.104 , pp. 3038-3045
    • Pardanani, A.1    Brockman, S.R.2    Paternoster, S.F.3
  • 3
    • 3042678647 scopus 로고    scopus 로고
    • Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias
    • Vandenberghe P, Wlodarska I, Michaux L, et al: Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias. Leukemia 18:734-742, 2004
    • (2004) Leukemia , vol.18 , pp. 734-742
    • Vandenberghe, P.1    Wlodarska, I.2    Michaux, L.3
  • 4
    • 33645666161 scopus 로고    scopus 로고
    • Atypical myeloproliferative disorders: Diagnosis and management
    • Tefferi A, Elliott MA, Pardanani A: Atypical myeloproliferative disorders: Diagnosis and management. Mayo Clin Proc 81:553-563, 2006
    • (2006) Mayo Clin Proc , vol.81 , pp. 553-563
    • Tefferi, A.1    Elliott, M.A.2    Pardanani, A.3
  • 5
    • 0037103624 scopus 로고    scopus 로고
    • Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta
    • Apperley JF, Gardembas M, Melo JV, et al: Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta. N Engl J Med 347:481-487, 2002
    • (2002) N Engl J Med , vol.347 , pp. 481-487
    • Apperley, J.F.1    Gardembas, M.2    Melo, J.V.3
  • 6
    • 33845991464 scopus 로고    scopus 로고
    • Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disorders
    • David M, Cross NC, Burgstaller S, et al: Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disorders. Blood 109:61-64, 2007
    • (2007) Blood , vol.109 , pp. 61-64
    • David, M.1    Cross, N.C.2    Burgstaller, S.3
  • 7
    • 33947588778 scopus 로고    scopus 로고
    • Fusion of H4/D10S170 to PDGFRbeta in a patient with chronic myelomonocytic leukemia and long-term responsiveness to imatinib
    • Drechsler M, Hildebrandt B, Kundgen A, et al: Fusion of H4/D10S170 to PDGFRbeta in a patient with chronic myelomonocytic leukemia and long-term responsiveness to imatinib. Ann Hematol 86:353-354, 2007
    • (2007) Ann Hematol , vol.86 , pp. 353-354
    • Drechsler, M.1    Hildebrandt, B.2    Kundgen, A.3
  • 8
    • 33947389297 scopus 로고    scopus 로고
    • A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan syndrome
    • La Starza R, Rosati R, Roti G, et al: A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan syndrome. Leukemia 21:830-833, 2007
    • (2007) Leukemia , vol.21 , pp. 830-833
    • La Starza, R.1    Rosati, R.2    Roti, G.3
  • 9
    • 0942276859 scopus 로고    scopus 로고
    • Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome
    • Klion AD, Robyn J, Akin C, et al: Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood 103:473-478, 2004
    • (2004) Blood , vol.103 , pp. 473-478
    • Klion, A.D.1    Robyn, J.2    Akin, C.3
  • 10
    • 38349101871 scopus 로고    scopus 로고
    • Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms
    • Tefferi A, Vardiman JW: Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 22:14-22, 2008
    • (2008) Leukemia , vol.22 , pp. 14-22
    • Tefferi, A.1    Vardiman, J.W.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.